A significant divergence in institutional investment strategy is unfolding around Visa Inc., the global payments network. Recent regulatory filings reveal that while one major fund has substantially reduced its stake, other prominent institutional players are using current market conditions to increase their holdings, painting a picture of expert disagreement on the stock’s near-term trajectory.
Conflicting Moves Among Major Holders
The most notable shift comes from The Growth Fund of America, managed by Capital Group, which sold approximately 1.8 million Visa shares. This transaction reduced its position by about 21%. Despite this reduction, the fund retains a substantial investment valued at roughly $2.26 billion. In a contrasting move, Swiss Life Asset Management expanded its stake by 4.7%, elevating Visa into its portfolio’s top twenty holdings.
Further complexity is evident within Capital Group’s own suite of funds. While its flagship fund sold shares, other specialized vehicles under the same umbrella took opposing actions. The Capital Group Growth ETF boosted its Visa holdings by more than 17%, and the Capital Group New Geography Equity ETF executed a massive increase of nearly 49%. This internal disagreement suggests deep divisions among market experts regarding future consumer trends and their impact on worldwide payment systems.
Should investors sell immediately? Or is it worth buying Visa?
Robust Fundamentals Amid Share Price Weakness
Despite the shareholder turbulence, Visa’s underlying business performance remains exceptionally strong. The company continues to demonstrate remarkable operational efficiency, boasting a net profit margin above 50% and a return on equity close to 62%. Its latest quarterly results surpassed analyst expectations, with revenue reaching $10.9 billion—a year-over-year increase of 14.6%. This growth confirms the scalability of its business model even within a challenging economic climate. The stock currently trades at a price-to-earnings (P/E) ratio of 30.3.
The analyst community maintains a largely bullish outlook on the financial behemoth:
- Bank of America: $410.00 (Buy)
- Macquarie: $410.00 (Outperform)
- Consensus Price Target (39 analysts): $403.94
However, share price action tells a different story. The stock closed Friday at €261.20, hovering just above a 52-week low of €258.60 set the previous Thursday. Since the start of the year, Visa shares have declined approximately 11.7%. Technical indicators add another layer of caution: a Relative Strength Index (RSI) reading of 72.3 points to a technically overbought condition. This is coupled with a notable rise in put option activity, signaling that some market participants are hedging against near-term downside risk. A consistent positive for income-focused investors is the dividend, which Visa increased in March for the seventeenth consecutive year.
Ad
Visa Stock: Buy or Sell?! New Visa Analysis from March 22 delivers the answer:
The latest Visa figures speak for themselves: Urgent action needed for Visa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 22.
Visa: Buy or sell? Read more here...









